Literature DB >> 6264298

Low temperature sustains inhibition of angiotensin-converting-enzyme activity in serum from patients taking captopril.

J L Imbs, D Bakish, M Schmidt, J Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6264298     DOI： 10.1056/NEJM198107233050425

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and biological effects of captopril and hydrochlorothiazide after acute and chronic administration either alone or in combination in hypertensive patients.

Authors:  J F Giudicelli; C Richer; A Mattei
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

2.  Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

Authors:  C Richer; B Giroux; P F Plouin; B Maarek; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

3.  Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.

Authors:  J F Giudicelli; M Chaignon; C Richer; B Giroux; J Guedon
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

4.  Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  M Azizi; A Rousseau; E Ezan; T T Guyene; S Michelet; J M Grognet; M Lenfant; P Corvol; J Ménard
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.